UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Breast cancer research and treatment, ISSN 0167-6806, 1/2017, Volume 161, Issue 2, pp. 363 - 373
Chemotherapy | Medicine & Public Health | Leukemia | Older patients | Oncology | Breast cancer | Myelodysplastic syndrome | Life Sciences & Biomedicine | Science & Technology | Age Factors | Follow-Up Studies | Humans | Leukemia, Myeloid, Acute - epidemiology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Risk | Leukemia, Myeloid, Acute - etiology | Myelodysplastic Syndromes - epidemiology | Breast Neoplasms - drug therapy | Myelodysplastic Syndromes - etiology | Breast Neoplasms - complications | Anthracyclines - administration & dosage | Neoplasms, Second Primary | Time Factors | Chemotherapy, Adjuvant - adverse effects | Aged, 80 and over | Female | Aged | Breast Neoplasms - epidemiology | Cohort Studies | Medical colleges | Cyclophosphamide | Anthracyclines | Adjuvant treatment | Product development | Risk factors | Cancer | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 03/2012, Volume 23, Issue 3, pp. 632 - 638
geriatrics | paclitaxel | breast cancer | geriatric oncology | neurotoxicity | elderly | Neurotoxicity | Breast cancer | Elderly | Geriatric oncology | Paclitaxel | Geriatrics | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Age Factors | Humans | Middle Aged | Kaplan-Meier Estimate | Paclitaxel - adverse effects | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Disease-Free Survival | Neoplasm Metastasis | Antineoplastic Agents - adverse effects | Breast Neoplasms - pathology | Adult | Breast Neoplasms - mortality | Female | Aged | Retrospective Studies | Index Medicus | Original
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 08/2020, Volume 182, Issue 3, pp. 631 - 642
Life Sciences & Biomedicine | Oncology | Science & Technology | Body Composition | Receptors, Estrogen - metabolism | Prognosis | Follow-Up Studies | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Breast Neoplasms - diagnostic imaging | Obesity - diagnostic imaging | Body Mass Index | Sarcopenia - diagnostic imaging | Breast Neoplasms - drug therapy | Obesity - pathology | Breast Neoplasms - pathology | Muscle, Skeletal - diagnostic imaging | Sarcopenia - pathology | Aged | Muscle, Skeletal - pathology | Cohort Studies | Women | Complications and side effects | Chemotherapy | Comorbidity | Analysis | Physiological aspects | Muscles | Breast cancer | Cancer | Index Medicus
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 06/2020, Volume 181, Issue 2, pp. 411 - 421
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2004, Volume 22, Issue 14_suppl, pp. 512 - 512
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 07/2004, Volume 22, Issue 14_suppl, pp. 512 - 512
Journal Article
Annals of oncology, ISSN 0923-7534, 12/2012, Volume 23, Issue 12, pp. 3075 - 3081
toxicity | antineoplastic combined chemotherapy protocols | geriatrics | patient compliance | medication adherence | breast neoplasms | Medication adherence | Antineoplastic combined chemotherapy protocols | Breast neoplasms | Toxicity | Patient compliance | Geriatrics | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Age Factors | Fluorouracil - analogs & derivatives | Capecitabine | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Methotrexate - therapeutic use | Breast Neoplasms - drug therapy | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Fluorouracil - therapeutic use | Methotrexate - adverse effects | Deoxycytidine - therapeutic use | Medication Adherence | Fluorouracil - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - adverse effects | Aged, 80 and over | Deoxycytidine - adverse effects | Female | Aged | Patient Compliance | Deoxycytidine - analogs & derivatives | Index Medicus | Original
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 7/2016, Volume 158, Issue 2, pp. 203 - 217
Oncology | Breast cancer | Medicine & Public Health | Weight gain | Endocrine treatment | Life Sciences & Biomedicine | Science & Technology | Antineoplastic Agents, Hormonal - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Humans | Risk Factors | Survival Analysis | Observational Studies as Topic | Quality of Life | Female | Treatment Outcome | Clinical Trials as Topic | Weight Gain | Breast Neoplasms - drug therapy | Medical research | Care and treatment | Mortality | Adjuvant treatment | Medicine, Experimental | Tamoxifen | Risk factors | Cancer | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2003, Volume 21, Issue 8, pp. 1431 - 1439
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Breast Neoplasms - surgery | Multivariate Analysis | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Drug Administration Schedule | Humans | Middle Aged | Proportional Hazards Models | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Treatment Outcome | Recombinant Proteins | Granulocyte Colony-Stimulating Factor - therapeutic use | Breast Neoplasms - drug therapy | Filgrastim | Survival Analysis | Adult | Female | Aged | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 03/2003, Volume 21, Issue 6, pp. 976 - 983
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Chemotherapy | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Humans | Middle Aged | Proportional Hazards Models | Treatment Outcome | Lymphatic Metastasis | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Disease-Free Survival | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Adult | Female | Aged | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Index Medicus
Journal Article
British journal of cancer, ISSN 0007-0920, 07/2011, Volume 105, Issue 2, pp. 189 - 193
breast cancer | geriatric oncology | elderly | Life Sciences & Biomedicine | Oncology | Science & Technology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Biological and medical sciences | Medical sciences | Tumors | Age Factors | Humans | Mastectomy - methods | Combined Modality Therapy | Breast Neoplasms - therapy | Breast Neoplasms - pathology | Carcinoma - epidemiology | Age of Onset | Aged, 80 and over | Carcinoma - therapy | Female | Neoadjuvant Therapy | Aged | Carcinoma - pathology | Neoplasm Staging | Breast Neoplasms - epidemiology | Index Medicus | Minireview
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 10/2019, Volume 177, Issue 3, pp. 569 - 579
Muscle measures | Sarcopenia | Oncology | Breast cancer | Medicine & Public Health | Myosteatosis | Life Sciences & Biomedicine | Science & Technology | Body Composition | Prognosis | Humans | Patient Outcome Assessment | Disease Progression | Breast Neoplasms - therapy | Breast Neoplasms - complications | Breast Neoplasms - pathology | Sarcopenia - etiology | Sarcopenia - pathology | Female | Muscle, Skeletal - pathology | Breast Neoplasms - epidemiology | Care and treatment | Cancer patients | Chemotherapy | Patient outcomes | Oncology, Experimental | Physiological aspects | Muscles | Development and progression | Research | Cancer | Index Medicus
Journal Article